Since the expression of NOX4 was relatively high not only in urothelial carcinoma cells but also in dysplasia as precancerous lesions, we hope to develop prophylaxis against bladder cancer occurrence and recurrence with a new strategy focusing on the NOX4-ROS signal. This evidence concerns the gene NOX4 and urothelial carcinoma.